RESUMEN
AIMS: To estimate the prevalence of chronic kidney disease (CKD), their risk factors the incidence of cardiovascular and coronary events and total and cardiovascular mortality in a cohort of type 2 diabetes (T2DM) patients observed for 10 years in primary care practices in Badajoz, Spain. METHODS: Observational, longitudinal study. A total of 643 patients with T2DM (mean age 64.0 years, 55.7% women), without evidence of cardiovascular disease, were studied. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2 at the beginning of the study, by applying the simplified Modification of Diet in Renal Disease (MDRD) Study formula. RESULTS: The prevalence rate of CKD was 24.3%. Patients with CKD had higher percentages of coronary, cerebrovascular and cardiovascular events and higher rates of cardiovascular mortality (18.6 vs. 6.0%, p < 0.001) and total mortality (42.3 vs. 23.4%, p < 0.01), compared to patients without CKD. The Cox proportional hazards model, adjusted for age, systolic blood pressure levels, glycated haemoglobin, total cholesterol, obesity and smoking, revealed that patients with CKD had an increased risk of coronary events (HR:2.18; 95% CI:1.13-4.22, p < 0.05). CONCLUSIONS: Our study confirms a high prevalence of CKD in patients with T2DM and its relationship with the presence of cardiovascular disease.
Asunto(s)
Enfermedades Cardiovasculares , Diabetes Mellitus Tipo 2 , Insuficiencia Renal Crónica , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/epidemiología , Diabetes Mellitus Tipo 2/diagnóstico , Diabetes Mellitus Tipo 2/epidemiología , Femenino , Tasa de Filtración Glomerular , Factores de Riesgo de Enfermedad Cardiaca , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Prevalencia , Insuficiencia Renal Crónica/diagnóstico , Insuficiencia Renal Crónica/epidemiología , Factores de Riesgo , España/epidemiologíaRESUMEN
BACKGROUND AND OBJECTIVE: Patients with renal failure (RF) have an increased risk of cardiovascular events. The aims of the present study were: a) to evaluate if RF is an independent cardiovascular risk factor, and b) to analyze the predictive capacity of the original Framingham and REGICOR functions charts in patients with RF. PATIENTS AND METHOD: A total of 912 patients between 35-74 years old (average: 55.7 years; 56.4% female) with no evidence of cardiovascular disease, were included in the present study. The RF was defined in patients with a glomerular filtration < 60 ml/min (estimated with the equation of Cockroft-Gaukt). RESULTS: 13.5% of the patients presented RF criteria. The final rate of cardiovascular events was higher in the population with RF (21.1% vs 12.0%; p < 0.01; relative risk = 1.76; 95% confidence interval [CI], 1.19-2.59). Statistically significant differences were not found between men and women. The multiple logistic regression analysis showed that cigarette smoking (odds ratio [OR] = 2.17; 95% CI, 1.38-3.35), diabetes (OR = 2.08; 95% CI, 1.37-3.15), RF (OR = 1.83; 95% CI, 1.10-3.06), antihypertensive treatment (OR = 2.03; IC del 95%, 1.32-3.11), and hypertension (OR = 2.06; 95% CI, 1.06-4.05) were important factors for the prediction of coronary and cardiovascular events. The original Framingham function predicted suitably the coronary risk in the population with RF (18.3% versus 17.9%; p = 0.869) whereas REGICOR underestimated it (7.5% versus 17.9%; p < 0.05). The area under the receiver operator characteristic (ROC) curve obtained with the original Framingham function was similar to that of REGICOR function: 0.61 (95% CI, 0.47-0.75) and 0.62 (95% CI, 0.48-0.76), respectively. CONCLUSIONS: The RF behaves like an important cardiovascular risk factor. The area under ROC curve obtained with the original Framingham function was similar to that of REGICOR function.
Asunto(s)
Enfermedades Cardiovasculares/etiología , Insuficiencia Renal/complicaciones , Adulto , Anciano , Enfermedades Cardiovasculares/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Medición de Riesgo/estadística & datos numéricosAsunto(s)
Virus de la Hepatitis B/fisiología , Hepatitis B Crónica/etiología , Reinfección/etiología , Diálisis Renal , Activación Viral , Anciano de 80 o más Años , Antineoplásicos/efectos adversos , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Resultado Fatal , Femenino , Virus de la Hepatitis B/efectos de los fármacos , Humanos , Neoplasias Pulmonares/complicaciones , Neoplasias Pulmonares/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Activación Viral/efectos de los fármacosAsunto(s)
Monitoreo Epidemiológico , Hepatitis B/epidemiología , Hepatitis C/epidemiología , Infección Latente/epidemiología , Diálisis Renal , Antivirales/uso terapéutico , Hepatitis B/tratamiento farmacológico , Hepatitis C/tratamiento farmacológico , Humanos , Infección Latente/tratamiento farmacológicoAsunto(s)
Infecciones Asintomáticas , Virus de la Hepatitis B/aislamiento & purificación , Hepatitis B/virología , Diálisis Renal , ADN Viral/análisis , Hepatitis B/diagnóstico , Hepatitis B/prevención & control , Hepatitis B/transmisión , Anticuerpos contra la Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/sangre , Vacunas contra Hepatitis B/administración & dosificación , Virus de la Hepatitis B/genética , Virus de la Hepatitis B/fisiología , Humanos , Prevención Secundaria , Carga Viral , Activación ViralRESUMEN
No disponible
Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Anciano de 80 o más Años , Virus de la Hepatitis B/efectos de los fármacos , Hepatitis B/diagnóstico , Diálisis Renal , Activación Viral/efectos de los fármacos , Inmunosupresores/uso terapéutico , Virus de la Hepatitis B/aislamiento & purificación , Hepatitis B/transmisión , Carga Viral , SeroconversiónRESUMEN
No disponible
Asunto(s)
Humanos , Virosis/epidemiología , Diálisis Renal , Monitoreo Epidemiológico , Virosis/prevención & control , Hepatitis C/tratamiento farmacológico , Hepatitis B/tratamiento farmacológico , Antivirales/uso terapéuticoRESUMEN
No disponible
Asunto(s)
Humanos , Infecciones Asintomáticas , Hepatitis B/virología , Virus de la Hepatitis B/aislamiento & purificación , Diálisis Renal , ADN Viral/análisis , Hepatitis B/diagnóstico , Hepatitis B/prevención & control , Hepatitis B/transmisión , Anticuerpos contra la Hepatitis B/sangre , Antígenos de Superficie de la Hepatitis B/sangre , Vacunas contra Hepatitis B/administración & dosificación , Virus de la Hepatitis B/genética , Virus de la Hepatitis B/fisiología , Prevención Secundaria , Carga Viral , Activación ViralRESUMEN
OBJECTIVE: The objective of this work was to value the relationship between cardiovascular disease and presence of hidden renal failure in patients between 35 and 74 years followed up for 10 years. DESIGN: Observational, longitudinal, retrospective study of a cohort of patients. SETTING: Primary care health centre. PARTICIPANTS: We studied 875 patients (average age, 55.6 years, with 57.4% women) without evidence of cardiovascular disease, cared for in an urban primary health centre. MEASUREMENTS AND MAIN RESULTS: Glomerular filtration was estimated using Cockcroft-Gault and simplified MDRD equations. Hidden renal failure was considered if the glomerular filtration was <60 mL/min with a normal serum creatinine concentration. Using the Cockcroft-Gault equation 11.2% of study population had hidden renal failure and 12% when using MDRD, and 16.3% of patients with hidden renal failure using Cockcroft-Gault equation had coronary events. The relative risk in this group was 1.8 (95% confidence interval [CI], 1.1-2.9; P< .05). The percentage of coronary events was 16.2% when glomerular filtration was estimated by MDRD (relative risk, 1.9; 95% CI, 1.2-3.1; P< .05). Binary logistic regression analysis showed that age, male sex, smoking, diabetes, and diastolic pressure were the predicting variables of cardiovascular events, the highest odds ratio corresponding to the smoking population. The presence of hidden renal failure was not statistically significant using either Cockcroft (odds ratio, 1.21; 95% CI, 0.64-2.28; P=.566) or MDRD (odds ratio, 1.64; 95% CI, 0.77-3.48; P=.200) CONCLUSIONS: The prevalence of occult renal dysfunction in the 35-74 years population is high, but it does not behave as an independent cardiovascular risk factor.
Asunto(s)
Enfermedades Cardiovasculares/etiología , Insuficiencia Renal/complicaciones , Insuficiencia Renal/diagnóstico , Adulto , Anciano , Enfermedades Cardiovasculares/epidemiología , Femenino , Tasa de Filtración Glomerular , Humanos , Estudios Longitudinales , Masculino , Matemática , Persona de Mediana Edad , Insuficiencia Renal/fisiopatología , Estudios RetrospectivosRESUMEN
FUNDAMENTO Y OBJETIVO: El riesgo de presentar episodios cardiovasculares es elevado en pacientes con insuficiencia renal (IR). El presente estudio se diseñó con estos objetivos: a) evaluar si la IR se comporta como un factor independiente de riesgo cardiovascular, y b) analizar la capacidad predictiva de la función original de riesgo coronario de Framingham y la calibrada del REGICOR en pacientes con IR.PACIENTES Y MÉTODO: Se estudió a un total de 912 pacientes de 35-74 años (media, 55,7 años;un 56,4% de mujeres) sin evidencia de enfermedad cardiovascular, con un seguimiento de 10años. La IR se definió por la presencia de un filtrado glomerular estimado en la fórmula de Cockroft-Gault menor de 60 ml/min.RESULTADOS: El 13,5% de los pacientes reunía criterios de IR. La tasa final de episodios cardiovascularesfue superior en la población con IR (un 21,1 frente a un 12,0%; p < 0,01; riesgo relativo= 1,76; intervalo de confianza [IC] del 95%, 1,19-2,59), sin diferencias estadísticamente significativas entre varones y mujeres. En el análisis multivariante mediante regresión logística se mantuvieron como variables predictoras de eventos cardiovasculares el tabaquismo (odds ratio [OR] =2,17; IC del 95%, 1,38-3,35), la diabetes (OR = 2,08; IC del 95%, 1,37-3,15), la IR (OR =1,83; IC del 95%, 1,10-3,06), el tratamiento antihipertensivo (OR = 2,03; IC del 95%, 1,32-3,11) y la hipertensión arterial (OR = 2,06; IC del 95%, 1,06-4,05). La función original de Framingham predijo adecuadamente el riesgo coronario de la población con IR (un 18,3 frente a un 17,9%; p = 0,869), mientras que REGICOR lo infravaloró (un 7,5 frente a un 17,9%; p < 0,05). Las curvas de eficacia diagnóstica para la función original de Framingham y la REGICOR fueron similares: 0,61 (IC del 95%, 0,47-0,75) y 0,62 (IC del 95%, 0,48-0,76), respectivamente.CONCLUSIONES: La IR se comporta como un importante factor de riesgo cardiovascular. Las curvasde eficacia diagnóstica son similares en ambas funciones de riesgo coronario, Framingham y REGICOR
BACKGROUND AND OBJECTIVE: Patients with renal failure (RF) have an increased risk of cardiovascularevents. The aims of the present study were: a) to evaluate if RF is an independent cardiovascularrisk factor, and b) to analyze the predictive capacity of the original Framingham and REGICOR functions charts in patients with RF.PATIENTS AND METHOD: A total of 912 patients between 35-74 years old (average: 55.7 years; 56.4% female) with no evidence of cardiovascular disease, were included in the present study. The RF was defined in patients with a glomerular filtration < 60 ml/min (estimated with theequation of Cockroft-Gaukt).RESULTS: 13.5% of the patients presented RF criteria. The final rate of cardiovascular events washigher in the population with RF (21.1% vs 12.0%; p < 0.01; relative risk = 1.76; 95% confidenceinterval [CI], 1.19-2.59). Statistically significant differences were not found between men and women. The multiple logistic regression analysis showed that cigarette smoking (odds ratio [OR] = 2.17; 95% CI, 1.38-3.35), diabetes (OR = 2.08; 95% CI, 1.37-3.15), RF (OR = 1.83; 95% CI, 1.10-3.06), antihypertensive treatment (OR = 2.03; IC del 95%, 1.32-3.11), and hypertension(OR = 2.06; 95% CI, 1.06-4.05) were important factors for the prediction of coronary and cardiovascular events. The original Framingham function predicted suitably the coronary risk in the population with RF (18.3% versus 17.9%; p = 0.869) whereas REGICOR underestimated it (7.5% versus 17.9%; p < 0.05). The area under the receiver operator characteristic (ROC) curve obtained with the original Framingham function was similar to that of REGICOR function: 0.61(95% CI, 0.47-0.75) and 0.62 (95% CI, 0.48-0.76), respectively.CONCLUSIONS: The RF behaves like an important cardiovascular risk factor. The area under ROCcurve obtained with the original Framingham function was similar to that of REGICOR function
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Anciano , Ajuste de Riesgo , Insuficiencia Renal/complicaciones , Enfermedades Cardiovasculares/prevención & control , Factores de Riesgo , Insuficiencia Renal/fisiopatología , Enfermedades Cardiovasculares/epidemiología , Estudios RetrospectivosRESUMEN
Objetivo. Valorar la relación entremorbimortalidad cardiovascular y presenciade insuficiencia renal oculta en pacientesde 35-74 años de edad seguidos durante10 años.Diseño. Estudio observacional, longitudinal,de una cohorte retrospectiva.Emplazamiento. Atención primaria, centrode salud.Participantes. Un total de 875 pacientes(media, 55,6 años; 57,4%,mujeres) sinevidencia de enfermedad cardiovascular.Resultados y mediciones principales. El filtradoglomerular se estimó mediante las fórmulasde Cockcroft-Gault y MDRD abreviada,derivada del estudio Modification of Dietin Renal Disease. Se consideró insuficienciarenal oculta la presencia de un filtradoglomerular inferior a 60 ml/min con cifrasnormales de creatinina. Un 11,2% de lapoblación tenía insuficiencia renal ocultausando la fórmula de Cockcroft-Gaulty un 12,0% según MDRD. Un 16,3% delos pacientes con insuficiencia renal ocultaen la fórmula de Cockcroft-Gault presentaronacontecimientos coronarios (RR = 1,8; IC del95%, 1,1-2,9; p < 0,05). El porcentaje fuedel 16,2% (RR = 1,9; IC del 95%, 1,2-3,1;p < 0,05) cuando el filtrado glomerular se estimócon MDRD. En el análisis de regresiónlogística se observó que la edad, el sexo varón,el tabaquismo, la diabetes y la presión arterialdiastólica fueron las variables predictorasde episodios cardiovasculares en los modelosfinales, correspondiendo al tabaquismolas mayores odds ratio (OR). La presenciade insuficiencia renal oculta no alcanzósignificación estadística cuando la definiciónse realizó con la fórmula de Cockcroft-Gault(OR = 1,21; IC del 95%, 0,64-2,28;p = 0,566) o con la de MDRD (OR = 1,64;IC del 95%, 0,77-3,48; p = 0,200).Conclusiones. En pacientes de 35-74 añosexiste una alta prevalencia de insuficienciarenal oculta, pero esta entidad no secomporta como un predictor independientede episodios cardiovasculares
Objective. The objective of this work wasto value the relationship betweencardiovascular disease and presence ofhidden renal failure in patients between35 and 74 years followed up for 10 years.Design. Observational, longitudinal,retrospective study of a cohort of patients.Setting. Primary care health centre.Participants. We studied 875 patients(average age, 55.6 years, with 57.4% women)without evidence of cardiovascular disease,cared for in an urban primary health centre.Measurements and main results. Glomerularfiltration was estimated using Cockcroft-Gault and simplified MDRD equations.Hidden renal failure was considered if theglomerular filtration was <60 mL/min witha normal serum creatinine concentration.Using the Cockcroft-Gault equation 11.2%of study population had hidden renal failureand 12% when using MDRD, and 16.3%of patients with hidden renal failure usingCockcroft-Gault equation had coronaryevents. The relative risk in this groupwas 1.8 (95% confidence interval [CI],1.1-2.9; P<.05). The percentage ofcoronary events was 16.2% when glomerularfiltration was estimated by MDRD (relativerisk, 1.9; 95% CI, 1.2-3.1; P<.05). Binarylogistic regression analysis showed that age,male sex, smoking, diabetes, and diastolicpressure were the predicting variables ofcardiovascular events, the highest odds ratiocorresponding to the smoking population.The presence of hidden renal failure wasnot statistically significant using eitherCockcroft (odds ratio, 1.21; 95% CI, 0.64-2.28; P=.566) or MDRD (odds ratio, 1.64;95% CI, 0.77-3.48; P=.200)Conclusions. The prevalence of occult renaldysfunction in the 35-74 years populationis high, but it does not behave as anindependent cardiovascular risk factor